Healthcare

The work of our Healthcare business can help to make a difference to millions of lives. We put our patients at the center of everything we do.

Our Healthcare business aims to change lives

With a holistic approach, we design and develop medicines and intelligent devices that strive to provide ongoing care for patients beyond their treatment. This includes medications to treat conditions such as cancer or multiple sclerosis (MS). For example, we offer an injection device and disease monitoring software outside USA and Canada that allow patients with MS to self-inject their medicine and track its administration. With cancer, we are researching the use of biomarkers that can match potential treatment to individual patients.

Our goal is to support people at various stages of life. We have helped many women and couples achieve their dream of having a baby. As a global market leader in fertility treatments, we do what we do with passion – and we think further ahead. That’s why we complemented our legacy in fertility drug treatments with the launch of a dedicated Fertility Technologies unit to help improve treatment outcomes in the lab.

Our purpose. Our patients.

We are united As One for Patients to help create, improve and prolong lives.

This is our purpose – the reason why we do what we do every day. Working As One for Patients motivates us to always give our best and continuously improve our efforts.

Because we understand that every single one of us, every decision and contribution we make in our work has an impact on the lives of patients and their caregivers.

We are united As One for Patients.

Our therapeutic areas

Oncology

We are inspired by curiosity, science and, most importantly, patients, combining a creative approach with our relentless drive to transform the way cancer is treated.

Explore More

  1. Merkel Cell Carcinoma
  2. Head and Neck Cancer
  3. Colorectal Cancer
  4. Lung Cancer
  5. Oncology Treatments
  6. Oncology News Releases

Neurology & Immunology

We have more than 20 years of experience in Multiple Sclerosis (MS) care, and remains committed to finding solutions for patients’ significant unmet medical needs.

Explore More

  1. MULTIPLE SCLEROSIS
  2. MS INSIDE OUT
  3. MULTIPLE SCLEROSIS TREATMENTS
  4. VIDEO GALLERY
  5. WORLD MS DAY

Fertility

With our broad portfolio of treatment options, devices and advanced fertility technologies, we aim to contribute to improved treatment outcomes that help couples fulfill the dream of parenthood.

Explore More

  1. FERTILITY TREATMENTS
  2. FERTILITY TECHNOLOGIES

Endocrinology

Endocrine disorders such as growth hormone deficiency require long-term treatment. The treatments have a major effect on the patients’ wellbeing and can make a difference to their quality of life.

Explore More

  1. CHILDHOOD GROWTH HORMONE DEFICIENCY
  2. ADULT GROWTH HORMONE DEFICIENCY
  3. ENDOCRINOLOGY TREATMENTS

General Medicine

Combining our expertise in General Medicine, our purpose is to bring better health to our patients, helping them live their life to its full potential.

Explore More

  1. DIABETES
  2. Cardiovascular Diseases
  3. THYROID DISEASE
  4. TREATMENTS

Vibrant Thoughts Blog

Science and technology are transforming how we understand disease. Discover the people behind this innovation, and the vibrant thinking that drives them to make a difference for patients.

Explore More

  1. Vibrant Thoughts Blog

Related News

View All News
  1. Press Releases

    Future Insight Prize 2024 Awarded to Johns Hopkins University’s Lauren Gardner

    We awarded Lauren Gardner, representing Johns Hopkins University, Baltimore, USA, with the Future Insight Prize 2024 worth 500.000 € today.

    2024/07/10

  2. Press Releases

    Merck KGaA, Darmstadt, Germany, Provides Update on Xevinapant Program in Locally ...

    Merck KGaA, Darmstadt, Germany, today announced the discontinuation of the Phase III randomized TrilynX study.

    2024/06/24

  3. Press Releases

    Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) as a Standard ...

    Merck KGaA, Darmstadt, Germany today announced new real-world data that continue to reinforce the JAVELIN Bladder regimen as a standard of care.

    2024/01/22

We take a patient-directed approach each day, working with patients and caregivers to systematically incorporate their perspectives throughout our processes to shape the way we design and deliver healthcare.

learn more

Disclaimer

This publication is intended to provide information to an international audience. Not all products discussed on this page may be available in your country and local prescribing information and approved indications may differ from country to country. For local prescribing information and approved indications, please visit our local websites.